|Nixon's War on Drugs Has Lost All Legitimacy|
|Adam Sharp, Co-Founder, Early Investing|
|Editor's Note: Surprise, surprise... we're not the only ones talking about pot.|
Today's article comes from Early Investing co-founder Adam Sharp. He's on the hunt for great medical cannabis startups - as are many other investors who want to get in before the legalization boom.
And that's exactly what we've been doing in our monthly newsletter. In fact, our marijuana recommendations have scored gains ranging from 172%... to an amazing 582%!
For a chance to pocket gains like that yourself, click here.
- Rebecca Barshop, Managing Editor
An estimated 45 million arrests have been made in the U.S.
And the result? Drugs are still widely available, and profits for the cartels have never been higher.
A primary consequence of the war on drugs is that America has the highest incarceration rate in the world. With only 5% of the Earth's population, the U.S. holds 25% of all prisoners.
It's all a stunning misuse of taxpayer dollars. It blocks important research that needs to happen. And the human cost is incalculable.
It's simply no longer a justifiable battle - especially once you recognize the political agendas that drive policy.
The Drug War's Disturbing Roots
Back in 1994, writer Dan Baum interviewed Nixon's domestic policy advisor, John Ehrlichman, about the war on drugs.
Ehrlichman was instrumental in launching the war. (He also spent time in jail for Watergate crimes.) And what he had to say is shocking. As Baum recounted...
Thankfully, things are slowly turning around. States around the U.S. are legalizing marijuana at an increasing pace. And there's a growing worldwide movement that favors treating drug users for addiction over locking them up.
When society appears to be on the cusp of a change such as this, paying attention can pay dividends down the road. If the war on marijuana and other drugs truly is crumbling, the impacts will be more far-reaching than most expect.
For example, medical cannabis is already beginning to disrupt the pharmaceutical space. As I'll explain, it has the potential to take significant market share.
|Attention: Have you heard about this audacious new movement?! |
Starting with an announcement late in the day on September 26, 2018, American investors may be in for a nasty surprise. That's when one of the most popular assets in America could suddenly be made illegal.
Get prepared now. Learn the five (easy) steps to prepare yourself now. Click here to continue reading.
|Change = Opportunity|
Because marijuana has been illegal for so long, it's been very difficult for scientists to study.
The DEA (Drug Enforcement Administration) classifies marijuana as a Schedule I drug. In its world, it's a drug with "no currently accepted medical use and a high potential for abuse." It says it's worse than heroin, crack and meth, which are all considered Schedule II drugs (with some legitimate medical applications).
Being a Schedule I drug makes it nearly impossible to get government funding to study the medical uses of cannabis in the U.S. But researchers are finding a way. Mostly overseas, or with rare special permission in the U.S., the science is ongoing and extremely promising.
The real problem is that cannabis is a drug with far too many medical applications.
We know there's strong evidence for cannabis working for the following conditions: